Clinical TrialID 7356

Acute Effects of Cannabigerol

NCT05257044

Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7356
Evidence Id
7356
Core Evidence Id
7356
Source Clinical Trial Id
7350
Herb2 Clinical Trial Id
HBCT007350
Nct Id
NCT05257044
Title
Acute Effects of Cannabigerol
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Intervention
DRUG: Cannabigerol|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Double
Intervention Purpose
Basic_Science
Gender
All
Age
Adult, Older_Adult
Enrollment
34
Outcome Measure
Change in Mood, Participants will provide ratings of their mood using 0-10 scales, Change from baseline to approx. 20 minutes after CBG/placebo use|Change in Mood, Participants will provide ratings of their mood using 0-10 scales, Change from baseline to approx. 40 minutes after CBG/placebo use|Change in Mood, Participants will provide ratings of their mood using 0-10 scales, Change from baseline to approx. 60 minutes after CBG/placebo use|Change in Stress, Participants will provide ratings of their stress using 0-10 scales, Change from baseline to approx. 20 minutes after CBG/placebo use|Change in Stress, Participants will provide ratings of their stress using 0-10 scales, Change from baseline to approx. 40 minutes after CBG/placebo use|Change in Stress, Participants will provide ratings of their stress using 0-10 scales, Change from baseline to approx. 60 minutes after CBG/placebo use|Change in Anxiety, Participants will provide ratings of their anxiety using 0-10 scales and will complete the State Form of the State-Trait Anxiety Inventory, Change from baseline to approx. 20 minutes after CBG/placebo use|Change in Anxiety, Participants will provide ratings of their anxiety using 0-10 scales and will complete the State Form of the State-Trait Anxiety Inventory, Change from baseline to approx. 40 minutes after CBG/placebo use|Change in Anxiety, Participants will provide ratings of their anxiety using 0-10 scales and will complete the State Form of the State-Trait Anxiety Inventory, Change from baseline to approx. 60 minutes after CBG/placebo use
Sponsor Collaborator
Washington State University
Funded By
OTHER
Location
Washington State University, Pullman, Washington, 99164, United States
Other Id
19162
Start Date
2022-03-24
Primary Completion Date
2023-11-28
Completion Date
2023-11-28
First Posted
2022-02-25
Results First Posted
Last Update Posted
2024-04-25
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05257044
Title Cn
Title En
Acute Effects of Cannabigerol
Bilingual Status
semi_complete